Essex Investment Management’s Twist Bioscience TWST Stock Holding History

Essex Investment Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-317	Closed	-$4.78K	–	409
2023 Q1	$4.78K	Hold	317	–	–	﹤0.01%	374
2022 Q4	$8K	Sell	317 -27,849	-99%	-$808K	﹤0.01%	378
2022 Q3	$993K	Buy	28,166 +12,194	+76%	+$518K	0.16%	189
2022 Q2	$558K	Sell	15,972 -22,752	-59%	-$806K	0.09%	243
2022 Q1	$1.91M	Sell	38,724 -3,610	-9%	-$200K	0.24%	129
2021 Q4	$3.28M	Sell	42,334 -1,381	-3%	-$142K	0.38%	79
2021 Q3	$4.68M	Buy	43,715 +190	+0.4%	+$21.8K	0.57%	44
2021 Q2	$5.8M	Sell	43,525 -8,718	-17%	-$1.01M	0.67%	34
2021 Q1	$6.47M	Sell	52,243 -8,665	-14%	-$1.32M	0.79%	23
2020 Q4	$8.61M	Sell	60,908 -19,597	-24%	-$2.17M	1.07%	10
2020 Q3	$6.12M	Sell	80,505 -21,782	-21%	-$1.36M	0.88%	16
2020 Q2	$4.63M	Buy	+102,287	New	+$3.67M	0.76%	25

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Essex Investment Management's TWST Position: Q2 2023 in Review

Essex Investment Management sold out of Twist Bioscience (TWST) in Q2 2023, closing a stake of 317 shares — an estimated $4.78K sold.

Essex Investment Management first reported a position in TWST in Q2 2020 and held it in 12 quarters. The position peaked at $8.61M in Q4 2020. 194 funds tracked by Wall St. Rank hold TWST as of Q2 2023.

Essex Investment Management reported no remaining Twist Bioscience position as of Q2 2023 after selling out during the quarter.
Essex Investment Management sold 317 Twist Bioscience shares in Q2 2023, an estimated $4.78K.
Essex Investment Management first reported a position in Twist Bioscience in Q2 2020 and held it in 12 quarters.
Essex Investment Management's Twist Bioscience position peaked at $8.61M in Q4 2020.
194 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2023.

Based on Essex Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.